Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy

Published:2014-10-29 Issue:12 Volume:3 Page:e954868
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kim Young J¹²

Affiliation:

1. Department of Otolaryngology – Head & Neck Surgery; Johns Hopkins University; School of Medicine; Baltimore, MD USA

2. Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; School of Medicine; Baltimore, MD USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/21624011.2014.954868

Reference10 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

4. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

5. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis;Cancer Medicine;2023-12-27

2.

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram

;OncoTargets and Therapy;2020-11

3. Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review;International Journal of Molecular Sciences;2020-08-27

4. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging;European Radiology;2019-01-21

5. Molecular Mechanisms and Countermeasures of Immunotherapy Resistance in Malignant Tumor;Journal of Cancer;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3